Daily pill can double survival time for world’s deadliest cancer, trial shows

31 mai 2026 | Andrew Gregory Health editor in Chicago
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest (…)
 Site référencé:  The Guardian (Africa)

The Guardian (Africa) 

Marcia Lucas, Star Wars’ Oscar-winning editor and unsung hero, dies at 80
1er/06/2026
Ukraine war briefing : Big drone deal awaits Trump signature, says Zelenskyy
1er/06/2026
Colombia’s far-right presidential candidate Espriella wins first round of vote ahead of runoff
1er/06/2026
European leaders condemn Israel’s deepening incursion into Lebanon
1er/06/2026
Jamie Lee Curtis announces death of actor sister Kelly aged 69 : ‘My first friend and lifelong confidant’
1er/06/2026
Shared NHS patient records could cut 20,000 A&E visits a year, ministers claim
1er/06/2026